Navigation Links
Metamark Genetics, Inc. Announces New Chief Executive Officer
Date:11/5/2010

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Metamark Genetics, Inc., a privately held oncology molecular diagnostics company, announced today the appointment of Mark R. Straley as the company's President, Chief Executive Officer, and newest member of its Board of Directors. Kenneth E. Weg, a Metamark co-founder who previously served as interim CEO, will continue to serve as Chairman of the Board of Directors.

Mr. Straley brings twenty five years of experience to Metamark Genetics, Inc., as a proven General Manager with Sales and Marketing expertise in the Global Healthcare Industry. With particular focus on the Diagnostics and Diabetes markets, Mark has a demonstrated track record of increasing revenue and profitability. With both Fortune 100 company and start-up expertise, Mark has operated in multiple healthcare sectors in both developed and emerging markets.

Most recently, Mark was the Worldwide President of Johnson & Johnson's Diagnostics division accountable for $2B in revenue with global responsibility for sales, marketing, customer support and commercial operations. Mark joined Johnson & Johnson in 2005 as the Global Vice President of Marketing for the Diagnostics division. Prior to his assignment with J&J, Mr. Straley worked for such brand name companies as Bayer Healthcare and Abbott Laboratories where he held progressively responsible roles in sales, marketing and general management in several North American locations. Mark is a graduate of Miami University located in Oxford, Ohio with a Bachelor of Science in Marketing.

Kenneth E. Weg, Metamark's Chairman, stated, "Metamark is extremely fortunate to have attracted such a seasoned and successful diagnostics executive to serve as Chief Executive Officer. On behalf of the entire Company and Board of Directors, I welcome Mark to the team and look forward to his leadership."

When commenting on his decision to join Metamark, Mr. Straley stated, "There remains a significant unmet medical need among patients diagnosed with early-stage cancers and their physicians when considering the selection of the most appropriate treatment for that individual patient's tumor. The mission of Metamark is to empower personalized treatment decisions through innovative assays that report on the fundamental molecular determinants of metastatic risk. It is a rare opportunity to be able to join Metamark's team of world-renowned scientific and business leaders in pursuit of this mission."

Cautionary Note Regarding Forward-Looking Statements

This press release, and information contained on Metamark's website, contains forward-looking statements that involve substantial risks and uncertainties, including statements regarding Metamark's strategies and future plans, prospects and results, are forward-looking statements. The words "anticipate," "believe," "expect," "intend," "may," "plan," and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.  Metamark may not actually achieve the plans or expectations disclosed in its forward-looking statements, and you should not place undue reliance on its forward-looking statements.  


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Metamark Genetics, Inc. Announces New Chief Scientific Officer
2. Interleukin Genetics, Inc. Receives Delisting Notification from NYSE Amex
3. deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court
4. Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops
5. Bolder BioTechnology Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants
6. Cadence Pharmaceuticals Announces FDA Approval of OFIRMEV™ (acetaminophen) injection for the Management of Pain and Fever
7. IGEN NETWORKS ANNOUNCES THE APPOINTMENT OF TWO NEW MEMBERS TO THE ADVISORY BOARD
8. Elsevier Announces New Partnership With Canadian Cardiovascular Society to Publish the Canadian Journal of Cardiology
9. Advanced Life Sciences Announces US Army Collaboration to Research and Develop Restanza for the Treatment of Malaria
10. QuantaLife Announces Launch of Droplet Digital™ PCR System
11. diaDexus Announces Name Change From VaxGen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017   Bridge Patient Portal , an ... MD EMR Systems , an electronic medical record ... have established a partnership to build an interface ... GE Centricity™ products, including Centricity Practice Solution (CPS), ... These new integrations will allow healthcare delivery networks ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
Breaking Biology News(10 mins):